• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用一种新型定量系统鉴定和验证细胞焦亡模式以预测肺鳞状细胞癌的预后

Identification and validation of pyroptosis patterns with a novel quantification system for the prediction of prognosis in lung squamous cell carcinoma.

作者信息

Qin Xianyu, Wu Jiayan, Qin Fei, Zheng Yuzhen, Chen Junguo, Liu Zui, Tan Jian, Cai Weijie, He Shiyun, Jian Bozhu, Zheng Haosheng, Liao Hongying

机构信息

Department of Thoracic Surgery, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

出版信息

Transl Lung Cancer Res. 2024 Dec 31;13(12):3657-3674. doi: 10.21037/tlcr-24-1003. Epub 2024 Dec 27.

DOI:10.21037/tlcr-24-1003
PMID:39830751
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11736615/
Abstract

BACKGROUND

The role of pyroptosis in lung squamous cell carcinoma (LUSC) remains unclear. This study aimed to screen pyroptosis-related genes (PRGs) and construct a model to investigate the immune infiltration, gene mutations, and immune response of patients of LUSC.

METHODS

We conducted a comprehensive evaluation of pyroptosis patterns in patients with LUSC with 51 PRGs. Pyroptosis-related clusters were identified using consistency clustering algorithm. Differences in the biologic and clinical characteristics between the clusters were analyzed. Cox regression analysis was performed to screen for differentially expressed genes (DEGs) related to prognosis, and a principal component analysis (PCA) algorithm was used to construct a model based on these genes. The pyroptosis score was calculated for each tumor sample, and the samples were classified into high- and low-score groups based on the score. The disparities in survival, single-nucleotide variation (SNV), copy number variation (CNV), and immunotherapy response between high-score and low-score groups were analyzed.

RESULTS

A total of 51 PRGs were used to classify LUSC samples into three pyroptosis clusters with significant differences in survival (P=0.005). Based on the 390 DEGs between the three clusters, two distinct pyroptosis gene clusters were identified by secondary clustering, with significant differences in prognosis (P=0.005). A pyroptosis scoring model was established to evaluate the regulatory patterns of PRGs, and patients were stratified into two groups with high and low scores, using the median pyroptosis score as the cutoff. The survival analyses indicated that patients with high scores had worse prognoses in The Cancer Genome Atlas (TCGA)-LUSC cohort (P=0.002), which was further supported by the analysis of the GSE37745 (P=0.006) and GSE135222 datasets (P=0.02).

CONCLUSIONS

The quantification of pyroptosis patterns was found to be important in predicting prognosis and devising personalized treatment strategies in patients with LUSC.

摘要

背景

细胞焦亡在肺鳞状细胞癌(LUSC)中的作用仍不清楚。本研究旨在筛选细胞焦亡相关基因(PRG)并构建模型,以研究LUSC患者的免疫浸润、基因突变和免疫反应。

方法

我们用51个PRG对LUSC患者的细胞焦亡模式进行了综合评估。使用一致性聚类算法鉴定细胞焦亡相关簇。分析了各簇之间生物学和临床特征的差异。进行Cox回归分析以筛选与预后相关的差异表达基因(DEG),并使用主成分分析(PCA)算法基于这些基因构建模型。计算每个肿瘤样本的细胞焦亡评分,并根据该评分将样本分为高分和低分两组。分析高分和低分两组在生存、单核苷酸变异(SNV)、拷贝数变异(CNV)和免疫治疗反应方面的差异。

结果

共使用51个PRG将LUSC样本分为三个细胞焦亡簇,其生存存在显著差异(P = 0.005)。基于三个簇之间的390个DEG,通过二次聚类鉴定出两个不同的细胞焦亡基因簇,其预后存在显著差异(P = 0.005)。建立了细胞焦亡评分模型以评估PRG的调控模式,以细胞焦亡评分中位数为临界值将患者分为高分和低分两组。生存分析表明,高分患者在癌症基因组图谱(TCGA)-LUSC队列中的预后较差(P = 0.002),GSE37745(P = 0.006)和GSE135222数据集的分析进一步支持了这一点(P = 0.02)。

结论

发现细胞焦亡模式的量化对于预测LUSC患者的预后和制定个性化治疗策略很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3667/11736615/13d607851b10/tlcr-13-12-3657-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3667/11736615/94cfbe77f082/tlcr-13-12-3657-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3667/11736615/4ac80596550b/tlcr-13-12-3657-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3667/11736615/39cee8b70633/tlcr-13-12-3657-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3667/11736615/a060692b08b3/tlcr-13-12-3657-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3667/11736615/be61f77d6aa1/tlcr-13-12-3657-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3667/11736615/6bb4f905c43a/tlcr-13-12-3657-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3667/11736615/13d607851b10/tlcr-13-12-3657-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3667/11736615/94cfbe77f082/tlcr-13-12-3657-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3667/11736615/4ac80596550b/tlcr-13-12-3657-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3667/11736615/39cee8b70633/tlcr-13-12-3657-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3667/11736615/a060692b08b3/tlcr-13-12-3657-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3667/11736615/be61f77d6aa1/tlcr-13-12-3657-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3667/11736615/6bb4f905c43a/tlcr-13-12-3657-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3667/11736615/13d607851b10/tlcr-13-12-3657-f7.jpg

相似文献

1
Identification and validation of pyroptosis patterns with a novel quantification system for the prediction of prognosis in lung squamous cell carcinoma.利用一种新型定量系统鉴定和验证细胞焦亡模式以预测肺鳞状细胞癌的预后
Transl Lung Cancer Res. 2024 Dec 31;13(12):3657-3674. doi: 10.21037/tlcr-24-1003. Epub 2024 Dec 27.
2
Prediction of lung squamous cell carcinoma immune microenvironment and immunotherapy efficiency with pyroptosis-derived genes.基于细胞焦亡相关基因预测肺鳞癌免疫微环境及免疫治疗效果。
Medicine (Baltimore). 2022 Sep 16;101(37):e30304. doi: 10.1097/MD.0000000000030304.
3
Pyroptosis related genes signature predicts prognosis and immune infiltration of tumor microenvironment in hepatocellular carcinoma.焦亡相关基因signature 预测肝细胞癌肿瘤微环境的预后和免疫浸润。
BMC Cancer. 2022 Sep 20;22(1):999. doi: 10.1186/s12885-022-10097-2.
4
Integrative Analysis of Pyroptosis-Related Prognostic Signature and Immunological Infiltration in Lung Squamous Cell Carcinoma.肺鳞状细胞癌中焦亡相关预后特征与免疫浸润的综合分析。
Biomed Res Int. 2022 Jun 1;2022:4944758. doi: 10.1155/2022/4944758. eCollection 2022.
5
A novel pyroptosis-related lncRNA prognostic signature associated with the immune microenvironment in lung squamous cell carcinoma.一个与肺鳞癌免疫微环境相关的新型细胞焦亡相关长非编码 RNA 预后特征。
BMC Cancer. 2022 Jun 23;22(1):694. doi: 10.1186/s12885-022-09790-z.
6
Prediction of risk and clinical outcome of cuproptosis in lung squamous carcinoma.预测肺鳞癌中铜死亡风险和临床结局。
BMC Pulm Med. 2023 Jun 12;23(1):205. doi: 10.1186/s12890-023-02490-9.
7
A Novel Pyroptosis-Related Gene Signature for Early-Stage Lung Squamous Cell Carcinoma.一种用于早期肺鳞状细胞癌的新型焦亡相关基因特征
Int J Gen Med. 2021 Oct 5;14:6439-6453. doi: 10.2147/IJGM.S331975. eCollection 2021.
8
Pyroptosis-related long-noncoding RNA signature predicting survival and immunotherapy efficacy in patients with lung squamous cell carcinoma. pyroptosis 相关长非编码 RNA 标志物预测肺鳞癌患者的生存和免疫治疗疗效。
Clin Exp Med. 2024 Jul 3;24(1):145. doi: 10.1007/s10238-024-01409-w.
9
Identification of specific prognostic markers for lung squamous cell carcinoma based on tumor progression, immune infiltration, and stem index.基于肿瘤进展、免疫浸润和干细胞指数鉴定肺鳞状细胞癌的特定预后标志物。
Front Immunol. 2023 Sep 29;14:1236444. doi: 10.3389/fimmu.2023.1236444. eCollection 2023.
10
C6 and KLRG2 are pyroptosis subtype-related prognostic biomarkers and correlated with tumor-infiltrating lymphocytes in lung adenocarcinoma.C6 和 KLRG2 是与肺腺癌细胞焦亡亚型相关的预后生物标志物,与肿瘤浸润淋巴细胞相关。
Sci Rep. 2024 Oct 22;14(1):24861. doi: 10.1038/s41598-024-75650-4.

本文引用的文献

1
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
2
Pyroptosis: a double-edged sword in lung cancer and other respiratory diseases.细胞焦亡:肺癌及其他呼吸系统疾病的双刃剑
Cell Commun Signal. 2024 Jan 15;22(1):40. doi: 10.1186/s12964-023-01458-w.
3
Squamous cell lung cancer: Current landscape and future therapeutic options.
鳞状细胞肺癌:现状与未来治疗选择。
Cancer Cell. 2022 Nov 14;40(11):1279-1293. doi: 10.1016/j.ccell.2022.09.018. Epub 2022 Oct 20.
4
The emerging role of pyroptosis in pediatric cancers: from mechanism to therapy.细胞焦亡在儿科癌症中的新作用:从机制到治疗。
J Hematol Oncol. 2022 Oct 8;15(1):140. doi: 10.1186/s13045-022-01365-6.
5
Prediction of lung squamous cell carcinoma immune microenvironment and immunotherapy efficiency with pyroptosis-derived genes.基于细胞焦亡相关基因预测肺鳞癌免疫微环境及免疫治疗效果。
Medicine (Baltimore). 2022 Sep 16;101(37):e30304. doi: 10.1097/MD.0000000000030304.
6
Role of pyroptosis in inflammation and cancer.细胞焦亡在炎症和癌症中的作用。
Cell Mol Immunol. 2022 Sep;19(9):971-992. doi: 10.1038/s41423-022-00905-x. Epub 2022 Aug 15.
7
Integrative Analysis of Pyroptosis-Related Prognostic Signature and Immunological Infiltration in Lung Squamous Cell Carcinoma.肺鳞状细胞癌中焦亡相关预后特征与免疫浸润的综合分析。
Biomed Res Int. 2022 Jun 1;2022:4944758. doi: 10.1155/2022/4944758. eCollection 2022.
8
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.新辅助纳武利尤单抗联合化疗治疗可切除肺癌。
N Engl J Med. 2022 May 26;386(21):1973-1985. doi: 10.1056/NEJMoa2202170. Epub 2022 Apr 11.
9
Prognostic Implications of Pyroptosis-Related Gene Signatures in Lung Squamous Cell Carcinoma.肺鳞状细胞癌中焦亡相关基因特征的预后意义
Front Pharmacol. 2022 Jan 27;13:806995. doi: 10.3389/fphar.2022.806995. eCollection 2022.
10
Targeting mutant p53 for cancer therapy: direct and indirect strategies.针对癌症治疗的突变型 p53 靶点:直接和间接策略。
J Hematol Oncol. 2021 Sep 28;14(1):157. doi: 10.1186/s13045-021-01169-0.